Deep-Learning for Automatic Polyp Detection During Colonoscopy
Not Applicable
Completed
- Conditions
- Screening Colonoscopy
- Interventions
- Device: Computer Algorithm
- Registration Number
- NCT03637712
- Lead Sponsor
- NYU Langone Health
- Brief Summary
The primary objective of this study is to examine the role of machine learning and computer aided diagnostics in automatic polyp detection and to determine whether a combination of colonoscopy and an automatic polyp detection software is a feasible way to increase adenoma detection rate compared to standard colonoscopy.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 5
Inclusion Criteria
- Patients presenting for routine colonoscopy for screening and/or surveillance purposes.
- Ability to provide written, informed consent and understand the responsibilities of trial participation
Read More
Exclusion Criteria
- People with diminished cognitive capacity.
- The subject is pregnant or planning a pregnancy during the study period.
- Patients undergoing diagnostic colonoscopy (e.g. as an evaluation for active GI bleed)
- Patients with incomplete colonoscopies (those where endoscopists did not successfully intubate the cecum due to technical difficulties or poor bowel preparation)
- Patients that have standard contraindications to colonoscopy in general (e.g. documented acute diverticulitis, fulminant colitis and known or suspected perforation).
- Patients with inflammatory bowel disease
- Patients with any polypoid/ulcerated lesion > 20mm concerning for invasive cancer on endoscopy.
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Screening Colonoscopy Computer Algorithm Patients undergoing standard screening or surveillance colonoscopy will be included
- Primary Outcome Measures
Name Time Method Adenoma Detection Rate 1 Day the proportion of colonoscopic examinations performed that detect one or more polyp
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
NYU Langone Health
🇺🇸New York, New York, United States